1 |
Thijs RD,Surges R,Brien TJ,et al. Epilepsy in adults[J]. Lancet, 2019,393(10172):689.
|
2 |
Armijo JA,Valdizán EM,De CI,et al. Advances in the physiopathology of the epileptogenesis: Molecular aspects[J].Rev Neurol (Barc), 2002,34(5):409.
|
3 |
Ahern CA,Payandeh J, Bosmans F,et al. The hitchhiker's guide to the voltage-gated sodium channel galaxy[J]. Gen Physiol,2016,147(1):1.
|
4 |
Catterall WA,Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. nomenclature and structure-function relationships of voltage-gated sodium channels[J]. Pharmacol Rev,2005,57(4):397.
|
5 |
Inuzuka LM, Macedo-Souza LI, Della-Ripa B, et al. Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants: two new cases and review of the literature[J]. Brain Dev, 2020,42(2):211.
|
6 |
Catterall WA,Kalume F,Oakley JC. NaV1.1 channels and epilepsy[J]. Physiol,2010,588(Pt 11):1849.
|
7 |
O'Malley HA,Isom LL. Sodium channel beta subunits:emerging targets in channelopathies[J]. Annu Rev Physiol,2015,77:481.
|
8 |
Deng H, Xiu X, Song Z. The molecular biology of genetic-based epilepsies[J]. Mol Neurobiol,2014,49(1):352.
|
9 |
Kaplan DI,Isom LL,Petrou S. Role of sodium channels in epilepsy[J]. Cold Spring Harb Perspect,2016,6(6):1.
|
10 |
Barker BS,Young GT,Soubrane CH,et al. Ion channels[M]. London:Elsevier Academic Press, 2017:11.
|
11 |
Malo MS,Blanchard BJ, Andresen JM,et al. Localization of a putative human brain sodium channel gene (SCN1A) to chromosome band 2q24[J]. Cytogenet Genome Res,1994,67(3):178.
|
12 |
Mulley JC,Scheffer IE, Petrou S,et al. SCN1A mutations and epilepsy[J]. Human Mutation,2005,25(6) :535.
|
13 |
Guerrini R. Dravet syndrome:The main issues[J]. European Journal of Paediatric Neurology,2012,16(Suppl 1) :S1.
|
14 |
Yamakawa K. Molecular and cellular basis: Insights from experimental models of Dravet syndrome[J]. Epilepsia, 2011,52():70.
|
15 |
Colasante G, Lignani G, Brusco S, et al. dCas9-based scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in dravet syndrome mice[J]. Molecular Therapy, 2020,28(1):1.
|
16 |
Carvill GL,Engel KL,Ramamurthy A,et al. Aberrant inclusion of a poison exon causes dravet syndrome and related SCN1A-associated genetic epilepsies[J]. Am J Hum Genet,2018,103(6):1022.
|
17 |
Catterall WA. Sodium channels, inherited epilepsy, and antiepileptic drugs[J]. Annu Rev Pharmacol Toxicol,2014,54:317.
|
18 |
Syrbe S, Zhorov BS, Bertsche A, et al. Phenotypic variability from benign infantile epilepsy to ohtahara syndrome associated with a novel mutation in SCN2A[J].Mol Syndromol,2016,7(4):182.
|
19 |
Sanders SJ,Campbell AJ,Cottrell JR,et al. Progress in understanding and treating SCN2A-mediated disorders[J]. Trends Neurosci,2018,41(7):442.
|
20 |
Howell KB, McMahon JM, Carvill GL,et al. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures[J]. Neurology,2015,85(11):958.
|
21 |
Yamakawa K. Mutations of voltage-gated sodium channel genes SCN1A and SCN2A in epilepsy, intellectual disability, and autism[M]. Amsterdam: Elsevier Inc,2016:233.
|
22 |
Ben-Shalom R,Keeshen CM,Berrios KN,et al. Opposing effects on NaV1.2 function underlie differences between SCN2A variants observed in individuals with autism spectrum disorder or infantile seizures[J]. Biol Psychiatry,2017,82(3):224.
|
23 |
Mason ER, Wu F, Patel RR, et al. Resurgent and gating pore currents induced by De Novo SCN2A epilepsy mutations[J]. ENEURO,2019,6(5):141.
|
24 |
Whitaker WRJ,Clare JJ,Powell AJ,et al. Distribution of voltage-gated sodium channel-subunit and-subunit mRNAs in human hippocampal formation,cortex,and cerebellum[J]. Comp Neurol,2000,422(1):123.
|
25 |
Felts PA,Yokoyama S,Dib-Hajj S,et al. Sodium channel α-subunit mRNAs Ⅰ, Ⅱ, Ⅲ, NaG,Na6 and hNE (PN1):Different expression patterns in developing rat nervous system[J]. Mol Brain Res,1997,45(1):71.
|
26 |
Holland KD,Kearney JA,Glauser TA,et al. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy[J]. Neurosci Lett,2008,433(1):65.
|
27 |
Zaman T, Helbig I, Božović IB, et al. Mutations in SCN3A cause early infantile epileptic encephalopathy[J]. Ann Neurol,2018,83(4):703.
|
28 |
Cheah CS,Westenbroek RE,Roden WH, et al. Correlations in timing of sodium channel expression,epilepsy,and sudden death in Dravet syndrome[J]. Channels,2013,7(6):468.
|
29 |
Estacion M,Gasser A,Dib-Hajj SD,et al. A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons[J]. Exp Neurol,2010,224(2):362.
|
30 |
Sun G, Werkman TR, Battefeld A,et al. Carbamazepine and topiramate modulation of transient and persistent sodium currents studied in HEK293 cells expressing the Nav 1.3 subunit[J]. Epilepsia,2007,48(4):774.
|
31 |
Lamar T,Vanoye CG,Calhoun J,et al. SCN3A deficiency associated with increased seizure susceptibility[J]. Neurobiol Dis,2017,102:38.
|
32 |
Zaman T,Helbig I,Bozovic IB,et al. Mutations in cause early infantile epileptic encephalopathy[J]. Ann Neurol,2018,83(4):703.
|
33 |
Miyatake S,Kato M,Sawaishi Y,et al. Recurrent SCN3A p.Ile875Thr variant in patients with polymicrogyria[J]. Ann Neurol,2018,84(1):159.
|
34 |
Trujillano D,Bertoli-Avella AM,Kumar Kandaswamy K,et al. Clinical exome sequencing:Results from 2819 samples reflecting 1000 families[J]. Eur J Hum Genet,2017,25(2):176.
|
35 |
Smith RS,Kenny CJ,Ganesh V,et al. Sodium channel SCN3A (Na(V)1.3) regulation of human cerebral cortical folding and oral motor development[J]. Neuron,2018,99(5):905.
|
36 |
Inuzuka LM,Macedo-Souza LI,Della-Ripa B,et al. Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants:Two new cases and review of the literature[J]. Brain Dev,2019,42(2):211.
|
37 |
Tzoumaka E,Tischler AC,Sangameswaran L,et al. Differential distribution of the tetrodotoxin-sensitive rPN4/NaCh6/Scn8a sodium channel in the nervous system[J].Neurosci Res,2000,60(1):37.
|
38 |
Lopez-Santiago LF,Yuan Y,Wagnon JL,et al. Neuro-nal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy[J]. Proc Natl Acad Sci USA,2017,114(9):2383.
|
39 |
Apale LA,Paul KN,Sawyer NT,et al. Dysfunction of the scn8 avoltage-gated sodium channel alters sleep architecture,reduces diurnal corticosterone levels,and enhances spatial memory[J]. J Biol Chem,2010,285(22):16553.
|
40 |
Johannesen KM, Gardella E, Encinas AC,et al. The spectrum of intermediate SCN8A-related epilepsy[J]. Epilepsia,2019,60(5):830.
|
41 |
Veeramah KR,O’Brien JE,Meisler MH,et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP [J].American Journal of Human Genetics,2012,90(3):502.
|
42 |
Sun W,Wagnon JL,Mahaffey CL,et al. Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice[J]. Physiol,2013,591(1):241.
|
43 |
Makinson CD,Tanaka BS,Sorokin JM,et al. Regulation of thalamic and cortical network synchrony by Scn8a[J]. Neuron,2017,93(5):1165.
|
44 |
Yang C, Hua Y, Zhang W,et al. Variable epilepsy phenotypes associated with heterozygous mutation in the SCN9A gene:Report of two cases[J]. Neurol Sci,2018,39(6):1113.
|
45 |
Cummins TR,Howe JR,Waxman SG. Slow closed-state inactivation:a novel mechanism underlying ramp currents in cells expressing the hNE/PN1sodium chan-nel [J]. J Neurosci,1998,18(23):9607.
|
46 |
Rush AM,Dib-Hajj SD,Liu SJ,et al. A single sodium channel mutation produces hyper-or hypoexcit ability in different types of neurons[J]. Proc Natl Acad Scius A,2006,103(21):8245.
|
47 |
Emery EC,Lui ZAP,Word JN. Nav1.7 and other volt-age-gated sodium channels as drug targets for pain Relief [J].Expert Opin Ther Targets,2016,20(8):975.
|
48 |
Zhang T,Chen M,Zhu A,et al. Novel mutation of SCN9A gene causing generalized epilepsy with febrile seizures plus in a Chinese family[J]. Neurol Sci,2020,41(7):1913.
|
49 |
Cen Z,Lou Y,Guo Y,et al. Q10R mutation in SCN9A gene is associated with generalized epilepsy with febrile seizures plus[J]. Seizure,2017,50(6):186.
|
50 |
Wallace RH, Wang DW, Singh R,et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel sz1 subunit gene SCN1B[J]. Nat Genet,1998,19(4):366.
|
51 |
Patino GA, Claes LR, Lopez-Santiago LF,et al. A functional null mutation of SCN1B in a patient with Dravet syndrome[J]. Neurosci,2009,29(34):10764.
|
52 |
Chen C,Westenbroek RE,Xu X,et al.Mice lacking sodium channel beta1 subunits display defects in neuronal excitability,sodium channel expression,and nodal architecture[J]. Neurosci,2004,24(16):4030.
|
53 |
Ogiwara I, Nakayama T, Yamagata T,et al. A homozygous mutation of voltage-gated sodium channel beta(I) gene SCN1B in a patient with Dravet syndrome[J]. Epilepsia,2012,53(12):e200.
|
54 |
Gataullina S,Dulac O. From genotype to phenotype in Dravet disease[J]. Seizure,2017,44:58.
|
55 |
Fendri-Kriaa N,Kammoun F,Salem IH,et al. New mutation c.374C > T and a putative disease-associated haplotype within SCN1B gene in Tunisian families with febrile seizures[J]. Eur J Neurol,2011,18(5):695.
|
56 |
Wallace RH,Wang DW,Singh R,et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel sz1 subunit gene SCN1B[J]. Nat Genet,1998,19(4):366.
|
57 |
Scheffer IE,Harkin LA,Grinton BE,et al.Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations[J]. Brain,2007,130(Pt 1):100.
|
58 |
Patino GA,Brackenbury WJ,Bao Y,et al. Voltage-gated Na+channel beta1B: A secreted cell adhesion molecule involved in human epilepsy[J]. Neurosci,2011,31(41):14577.
|